Well Incentivized Open to everyone
Embed:
Loading Portfolio...
| id | rsymbol | Symbol | Current Price | Change (%) | Open | High | Low | Volume | Date Added | Cost per share | Quantity | Value | Value Weighting | Gain (%) | Gain ($) | Fair Value ($) | Note | Company | Exchange | Industry | Market Cap ($M) | Sales ($M) | Book Value | Debt to Equity | Yield | Payout | 10-Y Dividend Payout Range | Financial Strength | Profitability | Interest Coverage | 52-W Range | 1-W Change (%) | 4-W Change (%) | 52-W Change (%) | YTD Change (%) | Beta | Short Ratio | P/E | P/S | P/B | 10-Year P/E Range | 10-Year P/S Range | 10-Year P/B Range | PEG | 1-Year Revenue Growth Rate | 5-Year Revenue Growth Rate | 10-Year Revenue Growth Rate | 1-Year EBITDA Growth Rate | 5-Year EBITDA Growth Rate | 10-Year EBITDA Growth Rate | NCAV | Median PS Value | Graham Number | Peter Lynch Fair Value | Earnings Yield | Forward Rate of Return | Shiller P/E | EV/EBIT | EV/EBITDA | Predictability Rank | Operating Margin | Net Margin | Cash per Share | ROE | ROA | Altman Z Score | Piotroski F Score | Beneish M Score | EV/Sales |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 416319 | AZN | AZN | 51.71 | 0.21 (0.41%) | 51.12 | 51.79 | 51.00 | 1.7M | 09/25/2012 | 48.20 | 0 | 0.00 | 0% | 7.28% | 0.00 | Add | AstraZeneca PLC | NYSE(USA) | Drug Manufacturers - Major | 64375 | 27009 | 19.04 | 0.31 | 5.41 | 0.6185 | 0.549 1.599 |
48.8 | 66.1 | 18.9 | 39.72 52.27 |
1.02 | 0.96 | 29.14 | 13.41 | 0.64 | 100 | 11.42 | 2.40 | 2.70 | 5.74 32.5 |
1.32 6.54 |
2.26 9.82 |
4.2 | -11.8 | 1.2 | 8.9 | -23.6 | 2.7 | 20.8 | 5.89 | 48.66 | 0 | 0 | 11.20 | 11.14 | 9.4 | 8.9 | 6.60 |
![]()
Back Testing Results: Average gain of all 2.5-Star stocks: 7.3% per year. % of Stocks that are in still loss if held for 10yrs: 18%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
29.10 | 22.5 | -17.06 | 26.5 | 11.8 | 2.77 | 4 | -2.46 | -0.08 | |
| 416320 | CMI | CMI | 118.83 | 0.68 (0.58%) | 118.14 | 119.51 | 117.72 | 1.7M | 09/25/2012 | 95.19 | 0 | 0.00 | 0% | 24.83% | 0.00 | Add | Cummins Inc | NYSE(USA) | Diversified Industrials | 22417.6 | 16784 | 34.78 | 0.11 | 1.60 | 0.2442 | 0.093 6 |
69.2 | 76 | 322 | 82.2 122.54 |
3.51 | 10.99 | 20.95 | 10.13 | 2.01 | 196 | 15.27 | 1.34 | 3.40 | 4.44 50 |
0.15 1.68 |
0.7 4.84 |
0.6 | -8.6 | 10.3 | 9 | -27.7 | 24.4 | 19.9 | 15.51 | 44.81 | 79.33 | 189.97 | 8.80 | 27.07 | 20.2 | 11.4 | 9.34 |
![]()
Back Testing Results: Average gain of all 4-Star stocks: 9.8% per year. % of Stocks that are in still loss if held for 10yrs: 8%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
13.00 | 9.5 | -22.8 | 24.9 | 13.1 | 5.18 | 5 | -2.49 | 0.05 | |
| 416321 | MDT | MDT | 52.35 | 2.46 (4.93%) | 51.82 | 53.83 | 51.82 | 14M | 09/25/2012 | 43.72 | 0 | 0.00 | 0% | 19.74% | 0.00 | Add | Medtronic, Inc. | NYSE(USA) | Medical Devices | 50578.8 | 16427 | 16.88 | 0.43 | 1.99 | 0.312 | 0.178 0.389 |
58.8 | 81.8 | 31.3 | 35.67 53.83 |
4.87 | 13.73 | 41.62 | 28.25 | 0.9 | 255 | 15.97 | 3.29 | 3.20 | 9.85 50 |
1.92 10 |
2.05 10 |
1.5 | 3.3 | 6.6 | 10.7 | 18.2 | 10.5 | 6.7 | 3.69 | 82.89 | 17.61 | 35.55 | 7.70 | 15.63 | 18.2 | 13 | 10.67 |
![]()
Back Testing Results: Average gain of all 3.5-Star stocks: 9.3% per year. % of Stocks that are in still loss if held for 10yrs: 9%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
28.80 | 22.3 | -13.19 | 21.1 | 10.9 | 3.42 | 5 | -2.69 | -0.55 | |
| Summary | 1.12 (1.97%) | 0.00 | 17.28% | 0.00 | 14.22 | 2.34 | 3.1 | 14.22 | 2.34 | 3.1 |



RSS